ICL Group raises 2026 EBITDA guidance to $1.5–1.7B as Q1 2026 sales climb 14% on potash strength

ICL Group posted $2 billion in Q1 2026 consolidated sales, up 14% from $1.8 billion a year earlier, and raised its full-year adjusted EBITDA guidance by $100 million to a range of $1.5 billion to $1.7 billion, the company reported on May 13.

Adjusted EBITDA for the quarter rose 15% to $412 million. Net income attributable to shareholders reached $126 million, or $0.10 per share, up from $91 million in Q1 2025. Adjusted diluted EPS grew 22% to $0.11.

The Industrial Products unit outperformed on pricing power in bromine, while the Phosphate Solutions segment benefited from stronger commodity fertilizer markets — conditions the Tel Aviv-based group attributed in part to supply disruptions linked to the U.S.-Iran conflict and the partial closure of the Strait of Hormuz. Revenue growth was distributed across all four business segments.

The quarter also recorded ICL’s first contribution from Bartek Ingredients, a specialty chemical maker acquired in January to expand the company’s footprint in the North American food additives market. Net financial liabilities increased to $2.57 billion at quarter-end, reflecting debt taken on for that acquisition. ICL maintained its 2026 potash sales volume guidance at 4.5 million to 4.7 million tonnes.

The raised guidance signals management confidence that high bromine and potash prices will persist through the year, even as higher sulfur and raw material costs partially offset gains and currency headwinds from the shekel-dollar exchange rate linger. The company said it expects to continue expanding in specialty crop nutrition and specialty food solutions, with the Bartek integration adding steady earnings support from Q2 onward.

Source: Grafa